Observational Registry Study on Wilson Disease to Improve Diagnosis and Treatment Monitoring

What this Trial Is About

This research aims to study Wilson disease by following a group of patients over time at specialized centers in the United States and the United Kingdom. The study seeks to improve diagnosis and treatment monitoring for Wilson disease, particularly for patients receiving chelation therapy or zinc treatment. Researchers are also looking to find markers that could help guide future treatments for Wilson disease. Participants will be observed through a registry that collects data and specimens to support ongoing and future research. The study involves tracking patients health and treatment responses to better understand the diseases natural history and how current therapies work. This registry will support analysis of diagnostic scores and the development of biomarkers as potential treatment indicators. Participants will be asked to provide informed consent and may contribute data and biological samples over time to the registry. Researchers will measure outcomes such as the creation and maintenance of the Wilson disease registry over five years. The study focuses on collecting detailed and ongoing information to help guide future clinical trials and improve care for those with Wilson disease.

Natural History of Wilson Disease